Info@ThinkPinkRocks.com

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year.

Continue Reading:
Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Share

Leave a Reply